In animal models of sepsis, treatment with PD-L1 antibodies has been demonstrated to confer survival benefits [30], and PD-L1-deficient animals exhibit improved survival rates compared to wild-type counterparts [25]. This evidence concerns the gene CD274 and Sepsis.